Sputum Processing
The technique of sputum induction and processing is a recognised non-invasive method allowing the collection and analysis of cells from the airways, which is useful in various respiratory diseases like asthma, chronic obstructive pulmonary disease (COPD), chronic cough, or idiopathic pulmonary fibrosis.
PMS-IC via our collaboration with NHS Asthma Clinical trial teams have provided support to six clinical trials. The lab is GCLP compliant. Sputum processing is a critical component of precision medicine testing and diagnosis. Sputum is the mucus that originates from the lower respiratory tract and may contain microorganisms or other disease biomarkers. Sputum processing involves collecting a sample of the patient's sputum and subjecting it to various methods to extract and identify any potential disease-causing agents or biomarkers. The processing may involve culturing the sputum to identify the microorganisms, microscopy, and molecular diagnosis using technologies such as PCR or DNA sequencing. The analysis of sputum offers a non-invasive and cost-effective way to diagnose respiratory infections and other respiratory illnesses and helps clinicians select the most effective treatment for their patients, thus improving their overall health outcomes.
